Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS AUGUST ISSUE PUBLISHED
  • AUGUST 2020 Issue has been successfully launched on 1 August 2020.

Abstract

PRICING AND REIMBURSEMENT OF MEDICINES IN CENTRAL AND EAST EUROPEAN COUNTRIES

Mariela Marcheva, LublianaTosheva-Konteva, Guenka Petrova*

Medical University of Sofia, Faculty of Pharmacy, Bulgaria.

ABSTRACT

Each member state within EU 28 undertakes different actions when shaping pharmaceutical policy. Especially over the past years during the financial crisis governments face challenges of guaranteeing the population best access to medicines within the slim budgets. The Pharmaceutical Pricing and Reimbursement systems established by Member States are usually quite complex. Each country uses different schemes and policies, adapted to its own economic and health needs. These national systems are regularly reviewed or adapted in order to take account of political priorities, market evolutions and patients' needs. The European Commission's initiatives in the field of pricing and reimbursement therefore seek to foster cooperation through the establishment of a structured dialogue between the competent national authorities and all relevant stakeholders. The core objective is not only to enhance the functioning of the Internal Market, but also to ensure that national systems achieve an adequate balance between cost-containment, pharmaceutical innovation and patients' access to medicines.

Keywords: Pricing, Reimbursement, External Price Referencing, HTA, Europe.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More